SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: (Original Filing)
[Siliconware Precision Industries Co., Ltd Eva Chen Chief Financial Officer News Release]
[Siliconware Precision Industries Co., Ltd Eva Chen Chief Financial Officer News Release]
[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
[CONTENTS Chapter 1 Important Notice 1 Chapter 2 Basic Information on the Company 2 Chapter 3 Change in Share Capital and Shareholding of Major Shareholders 7 Chapter 4 Directors, Supervisors and Senior Management 12 Chapter 5 13 Chapter 6 Matters of Importance 24 Chapter 7 Financial Report (unaudited) 31 Chapter 8 Documents Available for Inspection 56] [TABLE OF CONTENTS 99.1: 2009 Interim Results dated August 26,2009 2 Guangshen Railway Company Limited Dated: August 27, 2009 Guo Xiang Dong Company Secretary 3 6-K 1 h03609e6vk.htm GUANGSHEN RAILWAY COMPANY LIMITED]
[eLong, Inc. Reports Second Quarter 2009 Unaudited Financial Results BEIJING, China August 27, 2009 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the second quarter ended June 30, 2009. Highlights Total gross revenues net revenues (figures in RMB million): Total gross revenues by product were as follows]
[REVISED: SINOVAC PROVIDES UPDATE ON CLINICAL TRIAL FOR H1N1 VACCINE TRIALS -H1N1 Vaccine Shows Good Safety Profile- BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers received their first shot of the vaccine] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[SINOVAC PROVIDES UPDATE ON CLINICAL TRIAL FOR H1N1 VACCINE TRIALS -H1N1 Vaccine Shows Good Safety Profile- BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1) BEIJING, July 22 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA), a leading provider of vaccines in China, today announced that it has initiated dosing today in its clinical trial of various Panflu vaccine candidates for pandemic influenza A (H1N1). Results are expected in September 2009.] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[eLong, Reports Second Quarter 2009 Unaudited Financial Results BEIJING, China August27, 2009 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for the second quarter ended June30, 2009. Highlights Total gross revenues net revenues (figures in RMB million): Total gross revenues by product were follows]
[Chunghwa Telecom Co., Ltd. Joseph C.P. Shieh Senior Vice President CFO Description 1 Press Release to Report Operating Results for the First Half of 2009 2 Financial Statements for the Six Months Ended June 30, 2009 and 2008 and Independent Auditors Report 3 Consolidated Financial Statements for the Six Months Ended June 30, 2009 and 2008 and Independent Auditors Report]
[Sinovac Adjourns 2008 Annual General Meeting BEIJING, July 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that its Annual General Meeting originally scheduled for July 16, 2009 has been adjourned to July 30, 2009. At the July 16, 2009 Annual General Meeting, the required quorum of a majority] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]